30.5.2007
•
News
M&A
KSB represents Glenmark Pharmaceuticals in acquisition of Medicamenta
Law firm Kocián Šolc Balaštík represented Indian pharmaceutical company Glenmark Pharmaceuticals Ltd. in concluding a deal via its Swiss subsidiary Glenmark Holding SA to acquire a majority shareholding in Medicamenta a.s., a company carrying out business activities in the production, sale and marketing of pharmaceutical products in the Czech Republic and Slovakia.
Glenmark Pharmaceuticals Ltd. is the Indian leader in the development of newmolecules in mainly inflammation and metabolic disorders. The company operatesin more than eighty countries worldwide and the acquisition of Medicamenta a.s.represents a strategic entry into two of the fastest growing markets in the EU.
Other articles
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
18.6.2025
•
News
KŠB Provided Legal Advisory in the Sale of ARETE Park Rokycany II to the REICO LONG LEASE Fund
Jiří Horník, Jakub Porod, and Yelizaveta Volodina assisted the ARETE group in the sale of the premium logistics complex ARETE Park Rokycany II. The buyer is the REICO LONG LEASE fund, managed by REICO Erste Asset Management. The fund primarily invests in logistics, industrial, retail, office, and other commercial properties, mainly in the Central European region.
17.6.2025
•
News
KŠB and Smetanova Litomyšl – a partnership with impact
Last weekend, as partners of the Smetanova Litomyšl festival, we had the honour of attending the opening concert of the festival’s 67th edition, featuring the Czech Philharmonic conducted by Jakub Hrůša and the exceptional Norwegian violinist Vilde Frang.
